Genzyme Corp said U.S. Patent Office approved patent company 's method testing serum alpha amylase , indicator pancreatic disease .
`` The patent strengthens Genzyme 's proprietary position leading independent supplier diagnostic enzyme substrate , '' Henri Temeer , Genzyme president , said .
The company said technology combine unique substrate two indicator enzyme diagnostic assay measure serum amylase level .
Genzyme said since 1985 entered several licensing agreement technology amylase test kit maker .
Reuter & # 3 ; 